Beta-Blockers — MOA & Clinical Use
Beta-blockers don't just slow the heart — they block the entire sympathetic stress response. Knowing which receptor they target tells you exactly which clinical problem they solve.
Core Concept
Beta-blockers work by competitively binding beta-adrenergic receptors, preventing catecholamines (epinephrine, norepinephrine) from activating the sympathetic fight-or-flight response. Beta-1 receptors live primarily in the heart. Blocking them decreases heart rate, contractility, and conduction velocity through the AV node — reducing myocardial oxygen demand. This is why beta-blockers are used for hypertension (especially with compelling indications such as post-MI or HFrEF), stable angina, heart failure with reduced ejection fraction, and rate control in atrial fibrillation. Beta-2 receptors live in the lungs and peripheral vasculature. Nonselective agents like propranolol block both beta-1 and beta-2; blocking beta-2 removes vasodilation (allowing unopposed alpha-1 vasoconstriction) and promotes bronchospasm — making them contraindicated in asthma and severe COPD. Cardioselective agents like metoprolol and atenolol preferentially block beta-1, sparing the lungs at lower doses. Carvedilol adds alpha-1 blockade, producing vasodilation on top of heart rate control — making it especially useful in heart failure. Critical nursing actions: hold for HR < 60 bpm or SBP < 90 mmHg, and never discontinue abruptly — rebound tachycardia and hypertensive crisis can result. The key clinical logic: beta-blockers reduce cardiac workload. Every approved indication traces back to that single mechanism.
Watch Out For
Don't confuse cardioselective (metoprolol, atenolol — beta-1 only) with nonselective (propranolol — beta-1 and beta-2). Selectivity is dose-dependent; at high doses, even cardioselective agents lose their lung-sparing advantage. Students often confuse beta-blockers (which decrease heart rate and contractility) with calcium channel blockers like amlodipine (which primarily vasodilate with minimal heart rate effect). Verapamil and diltiazem overlap more closely but work through a different mechanism.
Clinical Pearl
Think "-olol" = slow and low. These drugs lower heart rate, lower blood pressure, and lower myocardial oxygen demand — every indication connects to that triad.
Test Your Knowledge
3 quick questions — see how well you understood Beta-Blockers — MOA & Clinical Use